These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20213614)

  • 1. Intravitreal ranibizumab for choroidal neovascularization associated with retinal astrocytic hamartoma.
    Querques G; Kerrate H; Leveziel N; Coscas G; Soubrane G; Souied EH
    Eur J Ophthalmol; 2010; 20(4):789-91. PubMed ID: 20213614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.
    Shah NJ; Shah UN
    Indian J Ophthalmol; 2011; 59(4):318-9. PubMed ID: 21666322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal ranibizumab for type 3 choroidal neovascularization complicating adult onset foveomacular vitelliform dystrophy.
    Querques G; Querques L; Leveziel N; Bandello F; Souied EH
    J Fr Ophtalmol; 2013 Jan; 36(1):e1-4. PubMed ID: 23218864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with Stargardt's disease.
    Querques G; Bocco MC; Soubrane G; Souied EH
    Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):319-21. PubMed ID: 17934751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade.
    Cascavilla ML; Querques G; Querques L; Codenotti M; Bandello F
    Eur J Ophthalmol; 2013; 23(6):913-6. PubMed ID: 23813105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.
    Konstantinidis L; Mantel I; Zografos L; Ambresin A
    Eur J Ophthalmol; 2010; 20(5):955-8. PubMed ID: 20306440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 3 choroidal neovascularization associated with fundus flavimaculatus.
    Quijano C; Querques G; Massamba N; Soubrane G; Souied EH
    Ophthalmic Res; 2009; 42(3):152-4. PubMed ID: 19628956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
    Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
    Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.
    De Benedetto U; Battaglia Parodi M; Knutsson KA; Librando A; Bandello F; Lanzetta P; Iacono P
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):550-2. PubMed ID: 22554238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juxtafoveal choroidal neovascularization secondary to persistent placoid maculopathy treated with intravitreal bevacizumab.
    Parodi MB; Iacono P; Bandello F
    Ocul Immunol Inflamm; 2010 Oct; 18(5):399-401. PubMed ID: 20666681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
    Fung AE; Lalwani GA; Rosenfeld PJ; Dubovy SR; Michels S; Feuer WJ; Puliafito CA; Davis JL; Flynn HW; Esquiabro M
    Am J Ophthalmol; 2007 Apr; 143(4):566-83. PubMed ID: 17386270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of choroidal neovascularization in pathological myopia treated with intravitreal ranibizumab.
    Ladaique M; Dirani A; Ambresin A
    Klin Monbl Augenheilkd; 2015 Apr; 232(4):542-7. PubMed ID: 25902117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal Administration of Ranibizumab and Bevacizumab for Choroidal Neovascularization Secondary to Ocular Toxocariasis: A Case Report.
    Yoon DY; Woo SJ
    Ocul Immunol Inflamm; 2018; 26(4):639-641. PubMed ID: 27775459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
    Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
    Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microperimetric retinal changes in myopic choroidal neovascularization treated with intravitreal ranibizumab.
    Varano M; Tedeschi M; Oddone F; Perillo L; Coppè AM; Parravano M
    Retina; 2010 Mar; 30(3):413-7. PubMed ID: 20010453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swept-source optical coherence tomography angiography of choroidal neovascularization in vertically oriented oval dome-shaped maculopathy.
    Agarwal A; Aggarwal K; Gupta V;
    Indian J Ophthalmol; 2019 Aug; 67(8):1368-1371. PubMed ID: 31332147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration.
    Rothenbuehler SP; Waeber D; Brinkmann CK; Wolf S; Wolf-Schnurrbusch UE
    Am J Ophthalmol; 2009 May; 147(5):831-7. PubMed ID: 19217019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drastic effect of ranibizumab on choroidal neovascularization in idiopathic angioid streaks.
    Yolcu U; Gundogan FC; Diner O
    Arq Bras Oftalmol; 2015; 78(4):257-9. PubMed ID: 26375345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choroidal neovascularization in acquired partial lipodystrophy.
    Broadhead GK; Chang A
    Eur J Ophthalmol; 2013; 23(3):439-41. PubMed ID: 23483505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.